Admission Date:  [**2145-2-2**]              Discharge Date:   [**2145-2-10**]  Date of Birth:  [**2075-8-31**]             Sex:   F  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 242**] Chief Complaint: Epigastric pain  Major Surgical or Invasive Procedure: EGD Colonoscopy Barium swallow with small bowel follow-through   History of Present Illness: 69 year-old femalw with a past medical history significant for DM type 2, rheumatic valve disease s/p MVR with St-Judes valve in [**3-/2144**] on Coumadin therapy, s/p PPM for symptomatic bradycardia, as well as a history of CHF, who presents with a 3-day history of epigatric abdominal pain with radiation to the back, R>L.
In the ED, however, she refused IV placement, blood draws, T&S and admission.
Rheumatic mitral valve disease s/p valvuloplasty in 01/90, s/p St-Judes MVR in 03/[**2144**].
S/P VVI placement for symptomatic bradycardia in [**2120**].
Vitamin B12 deficiency anemia.
GI bleed: pt had GI bleed of unclear source before admission, likely [**2-10**] supratherapeutic INR in setting of coumadin therapy for MVR.
Coumadin was d/c on admission and the pt was placed on heparin gtt for anticoagulation in prep for workup for source of bleed.
Coumadin was restarted when no source of bleeding was identified, and heparin was continued until INR reached goal of 2.5-3.5, after which the heparin was d/c.
She will require f/u after d/c for coumadin monitoring.
MVR: the pt was initially supratherapeutic on coumadin w/ INR 11.
Coumadin was d/c until INR was normal.
Meanwhile, the pt was anticoagulated w/ heparin gtt as above.
When INR normalized, coumadin was restarted for goal INR of 2.5-3.5, and heparin was continued until INR reached goal as above.
The pt will need to continue coumadin after d/c.
Treatment was continued w/ her outpt dose of lasix w/ good effect.
DM2: pt's oral meds were held on admission in case of need for IV contrast.
Digoxin 250 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Gabapentin 300 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Furosemide 20 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily).
Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.)
Atorvastatin Calcium 10 mg Tablet Sig: One (1) Tablet PO once a day.
Glyburide 5 mg Tablet Sig: One (1) Tablet PO twice a day.
Metformin HCl 500 mg Tablet Sig: One (1) Tablet PO twice a day.
Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO BID (2 times a day).
Warfarin Sodium 5 mg Tablet Sig: One (1) Tablet PO once a day.
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO twice a day.
Spironolactone 25 mg Tablet Sig: One (1) Tablet PO twice a day.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Coumadin 2.5 mg Tablet Sig: One (1) Tablet PO 2 days per week (Monday, Thursday).
Digoxin 250 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Gabapentin 300 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Furosemide 20 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily).
Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.)
Atorvastatin Calcium 10 mg Tablet Sig: One (1) Tablet PO once a day.
Glyburide 5 mg Tablet Sig: One (1) Tablet PO twice a day.
Metformin HCl 500 mg Tablet Sig: One (1) Tablet PO twice a day.
Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO BID (2 times a day).
Warfarin Sodium 5 mg Tablet Sig: One (1) Tablet PO once a day.
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO twice a day.
Spironolactone 25 mg Tablet Sig: One (1) Tablet PO twice a day.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Coumadin 2.5 mg Tablet Sig: One (1) Tablet PO 2 days per week (Monday, Thursday).
GI bleed in setting of supertherapeutic INR  Secondary: Rhreumatic MV-s/p valvuloplasty and [**Hospital3 **] MVR in [**2144**] afib on coumadin s/p VVI pacer for symptomatic bradycardia CHF with normal EF DM-2 with neuropathy colonic polyps B12 deficiency   Discharge Condition: Good, with no GI bleeding, stable Hct.
Take medications as prescribed.
Present to [**Company 191**] coumadin clinic on Friday, [**2145-2-12**] for evaluation and leb testing.
